60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ:SXTP
Total Valuation
60 Degrees Pharmaceuticals, Inc. has a market cap or net worth of $3.73M. The enterprise value is -$98.60K.
Market Cap$3.73M
Enterprise Value-$98.60K
Share Statistics
60 Degrees Pharmaceuticals, Inc. has 2,472,949 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,472,949
Owned by Insiders3.23%
Owned by Institutions―
Financial Efficiency
60 Degrees Pharmaceuticals, Inc.’s return on equity (ROE) is -2.18 and return on invested capital (ROIC) is -220.20%.
Return on Equity (ROE)-2.18
Return on Assets (ROA)-1.37
Return on Invested Capital (ROIC)-220.20%
Return on Capital Employed (ROCE)-2.20
Revenue Per Employee335.16K
Profits Per Employee0.00
Employee Count3
Asset Turnover0.19
Inventory Turnover1.19
Valuation Ratios
The current PE Ratio of 60 Degrees Pharmaceuticals, Inc. is ―. 60 Degrees Pharmaceuticals, Inc.’s PEG ratio is 0.00219.
PE Ratio―
PS Ratio1.35
PB Ratio0.40
Price to Fair Value0.40
Price to FCF0.00
Price to Operating Cash Flow-0.12
PEG Ratio0.00219
Income Statement
In the last 12 months, 60 Degrees Pharmaceuticals, Inc. had revenue of 1.01M and earned -7.37M in profits. Earnings per share was -11.73.
Revenue1.01M
Gross Profit223.78K
Operating Income-7.76M
Pretax Income-7.37M
Net Income-7.37M
EBITDA-7.76M
Earnings Per Share (EPS)-11.73
Cash Flow
In the last 12 months, operating cash flow was -6.79M and capital expenditures -64.90K, giving a free cash flow of -6.86M billion.
Operating Cash Flow-6.79M
Free Cash Flow-6.86M
Free Cash Flow per Share-2.77
Dividends & Yields
60 Degrees Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.40
52-Week Price Change-80.03%
50-Day Moving Average3.02
200-Day Moving Average4.83
Relative Strength Index (RSI)35.29
Average Volume (3m)199.18K
Important Dates
60 Degrees Pharmaceuticals, Inc. upcoming earnings date is May 14, 2026, During Market Hours (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateMay 14, 2026
Ex-Dividend Date―
Financial Position
60 Degrees Pharmaceuticals, Inc. as a current ratio of 2.66, with Debt / Equity ratio of 0.00%
Current Ratio2.66
Quick Ratio2.30
Debt to Market Cap0.00
Net Debt to EBITDA0.19
Interest Coverage Ratio994.05
Taxes
In the past 12 months, 60 Degrees Pharmaceuticals, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
60 Degrees Pharmaceuticals, Inc. EV to EBITDA ratio is 0.02, with an EV/FCF ratio of 0.00.
EV to Sales-0.15
EV to EBITDA0.02
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
60 Degrees Pharmaceuticals, Inc. has $4.12M in cash and marketable securities with $153.76K in debt, giving a net cash position of $3.96M billion.
Cash & Marketable Securities$4.12M
Total Debt$153.76K
Net Cash$3.96M
Net Cash Per Share$1.60
Tangible Book Value Per Share$7.46
Margins
Gross margin is 22.26%, with operating margin of -771.64%, and net profit margin of -732.82%.
Gross Margin22.26%
Operating Margin-771.64%
Pretax Margin-732.82%
Net Profit Margin-732.82%
EBITDA Margin-771.64%
EBIT Margin0.00%
Analyst Forecast
The average price target for 60 Degrees Pharmaceuticals, Inc. is $24.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$24.00
Price Target Upside4700.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast192.72%
EPS Growth Forecast83.61%